Literature DB >> 11861279

Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells.

Yao-Qi Huang1, Jian-Jun Li, Liang Hu, Merlin Lee, Simon Karpatkin.   

Abstract

Angiogenesis is required for tumor growth and metastasis. It has recently been suggested that thrombin is a potent promoter of angiogenesis. We therefore examined the possibility that thrombin could be inducing the expression of angiopoietin-2 (Ang-2), necessary for remodeling. Human umbilical vein endothelial cells were incubated with or without thrombin (1 U/mL) for 1 to 24 hours and then examined for messenger RNA (mRNA) by Northern analysis. Enhanced mRNA expression (about 4-fold over baseline) was noted at 4 hours. Enhanced expression of Ang-2 mRNA was secondary to enhanced transcription (about 4-fold), with no effect on stabilization. Enhanced Ang-2 mRNA transcription was inhibited by H7 and PD98059, indicating the requirement of serine/threonine kinases as well as the mitogen-activated protein kinase pathway. Up-regulation of mRNA was associated with enhanced Ang-2 protein synthesis and secretion as assayed by immunoblot. Thrombin-induced secreted Ang-2 inhibited the binding of recombinant (35)S-Ang-1 to its Tie-2-Fc receptor, demonstrating functionality. Hirudin reversed this effect, demonstrating thrombin specificity. Thus, thrombin-induced tumorigenesis and metastasis is associated with enhanced Ang-2 protein synthesis and secretion via enhanced transcription of Ang-2. This could help explain how thrombin promotes angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861279     DOI: 10.1182/blood.v99.5.1646

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

Review 1.  Platelets: linking hemostasis and cancer.

Authors:  Shashank Jain; John Harris; Jerry Ware
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding.

Authors:  Corey E Tabit; Phetcharat Chen; Gene H Kim; Savitri E Fedson; Gabriel Sayer; Mitchell J Coplan; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  Circulation       Date:  2016-06-28       Impact factor: 29.690

3.  Angiopoietin-2: marker or mediator of angiogenesis in continuous-flow left ventricular assist device patients?

Authors:  Lauren K Truby; Veli K Topkara
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617.

Authors:  Nikolett Molnar; Dietmar W Siemann
Journal:  Microvasc Res       Date:  2012-02-23       Impact factor: 3.514

Review 5.  Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.

Authors:  Nikolett M Biel; Dietmar W Siemann
Journal:  Cancer Lett       Date:  2014-10-12       Impact factor: 8.679

Review 6.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

7.  Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.

Authors:  Eric T Alexander; Allyson R Minton; Candace S Hayes; Ashley Goss; Joanne Van Ryn; Susan K Gilmour
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 8.  Angiopoietin-2: development of inhibitors for cancer therapy.

Authors:  Bo Hu; Shi-Yuan Cheng
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

9.  An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice.

Authors:  Daniel Voskas; Yael Babichev; Ling S Ling; Jennifer Alami; Yuval Shaked; Robert S Kerbel; Brian Ciruna; Daniel J Dumont
Journal:  J Leukoc Biol       Date:  2008-05-01       Impact factor: 4.962

10.  Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients.

Authors:  Philipp Kümpers; Alexander Lukasz; Sascha David; Rüdiger Horn; Carsten Hafer; Robert Faulhaber-Walter; Danilo Fliser; Hermann Haller; Jan T Kielstein
Journal:  Crit Care       Date:  2008-11-21       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.